NBY logo

NovaBay Pharmaceuticals (NBY) Accounts Payable

Annual Accounts Payable

$1.13 M
+$50.00 K+4.63%

December 1, 2023

Summary

Performance

1-Year Change

+4.63%

3-Year Change

+274.17%

5-Year Change

+105.08%

15-Year Change

+142.49%

NBY Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.98%
NBY annual accounts payable is higher than 19.98% of companies in Healthcare sector

High & Low

All-time High

$2.48 M
NBY annual accounts payable is currently -54.49% below its historical high of $2.48 million

3-Year Low

$1.04 M
NBY annual accounts payable is currently +8.13% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NBY previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NBY next annual earnings announcement has not yet been scheduled

OtherNBYbalance sheetmetrics:

Annual Accounts Receivable

$759.00 K
NBY annual accounts receivable is $759.00 thousand

Annual Total Liabilities

$5.72 M
NBY annual total liabilities is $5.72 million

Annual Total Assets

$9.03 M
NBY annual total assets is $9.03 million

Annual Current Assets

$7.15 M
NBY annual total current assets is $7.15 million

Quarterly Accounts Payable

$396.00 K
-$839.00 K-67.94%

September 1, 2024

Summary

Performance

3-Month Change

-67.94%

1-Year Change

-58.18%

3-Year Change

-73.26%

5-Year Change

-73.26%

NBY Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.55%
NBY quarterly accounts payable is higher than 6.55% of companies in Healthcare sector

High & Low

All-time High

$2.87 M
NBY quarterly accounts payable is currently -86.20% below its historical high of $2.87 million

3-Year Low

$396.00 K
NBY quarterly accounts payable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYbalance sheetmetrics:

Quarterly Accounts Receivable

$704.00 K
NBY quarterly accounts receivable is $704.00 thousand

Quarterly Total Liabilities

$2.81 M
NBY quarterly total liabilities is $2.81 million

Quarterly Total Assets

$3.88 M
NBY quarterly total assets is $3.88 million

Quarterly Current Assets

$2.28 M
NBY quarterly total current assets is $2.28 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

NBY Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.6%-58.2%
3 y3 years+274.2%-73.3%
5 y5 years+105.1%-73.3%

NBY Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+8.1%-74.5%at low
5 y5-yearat high+274.2%-74.5%+90.4%
alltimeall time-54.5%+724.8%-86.2%+189.1%

NovaBay Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$396.00 K(-67.9%)
Jun 2024
-
$1.24 M(+10.6%)
Mar 2024
-
$1.12 M(-1.2%)
Dec 2023
$1.13 M(+4.6%)
$1.13 M(+19.3%)
Sep 2023
-
$947.00 K(-36.1%)
Jun 2023
-
$1.48 M(+29.0%)
Mar 2023
-
$1.15 M(+6.3%)
Dec 2022
$1.08 M(+3.3%)
$1.08 M(-1.5%)
Sep 2022
-
$1.10 M(+18.0%)
Jun 2022
-
$930.00 K(-40.2%)
Mar 2022
-
$1.56 M(+48.9%)
Dec 2021
$1.04 M(+246.0%)
$1.04 M(-22.8%)
Sep 2021
-
$1.35 M(+551.0%)
Jun 2021
-
$208.00 K(-75.0%)
Mar 2021
-
$833.00 K(+175.8%)
Dec 2020
$302.00 K(-8.8%)
$302.00 K(-62.1%)
Sep 2020
-
$796.00 K(-38.3%)
Jun 2020
-
$1.29 M(+114.5%)
Mar 2020
-
$602.00 K(+81.9%)
Dec 2019
$331.00 K(-39.9%)
$331.00 K(-34.2%)
Sep 2019
-
$503.00 K(+41.3%)
Jun 2019
-
$356.00 K(-22.9%)
Mar 2019
-
$462.00 K(-16.2%)
Dec 2018
$551.00 K(+18.2%)
$551.00 K(-2.3%)
Sep 2018
-
$564.00 K(+71.4%)
Jun 2018
-
$329.00 K(+9.3%)
Mar 2018
-
$301.00 K(-35.4%)
Dec 2017
$466.00 K(+2.4%)
$466.00 K(+30.9%)
Sep 2017
-
$356.00 K(-60.8%)
Jun 2017
-
$908.00 K(+13.8%)
Mar 2017
-
$798.00 K(+75.4%)
Dec 2016
$455.00 K(-81.7%)
$455.00 K(+17.6%)
Sep 2016
-
$387.00 K(-55.0%)
Jun 2016
-
$860.00 K(-52.7%)
Mar 2016
-
$1.82 M(-26.7%)
Dec 2015
$2.48 M
$2.48 M(-13.5%)
DateAnnualQuarterly
Sep 2015
-
$2.87 M(+61.5%)
Jun 2015
-
$1.78 M(-18.4%)
Mar 2015
-
$2.18 M(+16.8%)
Dec 2014
$1.86 M(+11.4%)
$1.86 M(+103.2%)
Sep 2014
-
$918.00 K(+76.5%)
Jun 2014
-
$520.00 K(+6.8%)
Mar 2014
-
$487.00 K(-70.9%)
Dec 2013
$1.67 M(+267.9%)
$1.67 M(+65.3%)
Sep 2013
-
$1.01 M(+65.8%)
Jun 2013
-
$611.00 K(+13.4%)
Mar 2013
-
$539.00 K(+18.5%)
Dec 2012
$455.00 K(-3.6%)
$455.00 K(-56.7%)
Sep 2012
-
$1.05 M(+16.6%)
Jun 2012
-
$901.00 K(+105.2%)
Mar 2012
-
$439.00 K(-7.0%)
Dec 2011
$472.00 K(+16.3%)
$472.00 K(+47.5%)
Sep 2011
-
$320.00 K(-28.6%)
Jun 2011
-
$448.00 K(+29.5%)
Mar 2011
-
$346.00 K(-14.8%)
Dec 2010
$406.00 K(+49.3%)
$406.00 K(+39.5%)
Sep 2010
-
$291.00 K(-32.0%)
Jun 2010
-
$428.00 K(+88.5%)
Mar 2010
-
$227.00 K(-16.5%)
Dec 2009
$272.00 K(-33.0%)
$272.00 K(-13.4%)
Sep 2009
-
$314.00 K(-41.1%)
Jun 2009
-
$533.00 K(+45.2%)
Mar 2009
-
$367.00 K(-9.6%)
Dec 2008
$406.00 K(+185.9%)
$406.00 K(-11.2%)
Sep 2008
-
$457.00 K(-18.1%)
Jun 2008
-
$558.00 K(-16.0%)
Mar 2008
-
$664.00 K(+367.6%)
Dec 2007
$142.00 K(-61.1%)
$142.00 K(-58.1%)
Sep 2007
-
$339.00 K(+109.3%)
Jun 2007
-
$162.00 K(-62.8%)
Mar 2007
-
$436.00 K(+19.5%)
Dec 2006
$365.00 K(+166.4%)
$365.00 K(+166.4%)
Dec 2005
$137.00 K
$137.00 K

FAQ

  • What is NovaBay Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual accounts payable year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly accounts payable year-on-year change?

What is NovaBay Pharmaceuticals annual accounts payable?

The current annual accounts payable of NBY is $1.13 M

What is the all time high annual accounts payable for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual accounts payable is $2.48 M

What is NovaBay Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, NBY annual accounts payable has changed by +$50.00 K (+4.63%)

What is NovaBay Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of NBY is $396.00 K

What is the all time high quarterly accounts payable for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly accounts payable is $2.87 M

What is NovaBay Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, NBY quarterly accounts payable has changed by -$551.00 K (-58.18%)